Targeted nanotechnology works by designing nanoparticles or nanocarriers equipped with specific ligands or antibodies that can recognize and bind to unique markers on the target site. Once bound, these nanoparticles can deliver therapeutic agents directly to the target, ensuring a higher concentration of the drug at the disease site.
